The prevalence and burden of symptoms amongst cancer patients attending palliative care in two African countries
Section snippets
Background
The lack of developed cancer registries in many countries in Africa hampers the collection of robust surveillance data to determine incidence and mortality, with fewer than 1% of abstracts within the global cancer registration literature originating from Africa.1 Data to inform evidence-based clinical practice are urgently needed to improve outcomes for Africans affected by cancer, as by 2030 the developing world is expected to bear 70% of the global cancer burden.2 GLOBCAN estimates that there
Methods
This study used an international multi-centred cross-sectional design utilising a well-validated cancer symptom scale.
Sample characteristics
One hundred and twelve cancer patients were recruited. The mean age was 56.6 years (SD = 15.8), and 72 (64.3%) were female. The place of care and recruitment was as follows: home care n = 94 (83.9%), inpatient n = 8 (7.1%), outpatient 9 (8.0%), daycare n = 1 (1.9%). Patients had been under palliative care for a median 52 weeks. Respondents’ home location was: urban n = 49 (43.8%); peri-urban n = 31 (27.7%); rural n = 32 (28.6%). Of the 112 patients, n = 73 (65.2%) were responsible for children (mean number of
Discussion
The data presented in this paper are the first to determine the symptom prevalence and burden amongst advanced cancer patients in Sub-Saharan Africa. It is interesting to note that pain and psychological problems were three of the five most common symptoms, found in more than two out of three patients. These data can inform the planning and delivery of appropriate care for Africans with advanced cancer.
We have compared our findings to available MSAS data reporting cancer patient studies: 66
Author contributions
The study was conceived by RH and IJH, design input by all authors, analysis conducted by RH and LS, all authors commented on further analysis and interpretation, and on draft manuscript.
Conflict of interest statement
The authors declare that they have no conflicting interests.
Acknowledgements
We are grateful to the BIG Lottery Fund UK for supporting this study under grant number IG/1/010141040. We would also like to acknowledge the clinical teams in each participating site who assisted in recruitment and to the patients and families who agreed to give data. The study sponsor (the BIG Lottery Fund UK) had no role in study design; the collection, analysis and interpretation of data; the writing of the report or the decision to submit the paper for publication.
References (27)
- et al.
Part I: Cancer in indigenous Africans–burden, distribution, and trends
Lancet Oncol
(2008) - et al.
Cancer survival in Africa, Asia, and Central America: a population-based study
Lancet Oncol
(2010 Feb) Childhood cancer treatment in developing countries
Lancet
(2005)- et al.
Palliative care in sub-Saharan Africa
Lancet
(2005) - et al.
A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease
J Pain and Symptom Manage
(2006) - et al.
Advancing palliative care as a human right
J Pain Symptom Manage
(2009) - et al.
Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale
J Pain Symptom Manage
(2003) - et al.
Study of unmet needs in symptomatic veterans with advanced cancer: incidence, independent predictors and unmet needs outcome model
J Pain Symptom Manage
(2004) - et al.
New insights in symptom assessment: the Chinese versions of the memorial symptom assessment scale short form (MSAS-SF) and the condensed MSAS (CMSAS)
J Pain Symptom Manage
(2008 Dec) Explanatory models of and attitudes towards cancer in different cultures
Lancet Oncol
(2004)